✨ Tazarotene (CAS 118292-40-3) - Product Overview ✨
Tazarotene is a third-generation topical retinoid widely used in dermatology for its potent efficacy in regulating skin cell proliferation and differentiation. It primarily treats psoriasis, acne vulgaris, and photoaging, while also demonstrating anti-inflammatory and comedolytic properties. Suitable for pharmaceutical formulations, cosmetic products, and clinical research, Tazarotene is a versatile active ingredient trusted by healthcare professionals worldwide.
🌟 Key Benefits of Tazarotene 🌟
✅ Rapid Action: Clinically proven to reduce psoriatic plaques by 60-70% within 12 weeks[^1].
✅ High Efficacy: 85% patient satisfaction in improving acne severity and skin texture[^2].
✅ Minimal Irritation: Optimized formulations reduce redness and dryness compared to traditional retinoids.
✅ Dual Functionality: Combats both acne and signs of aging, streamlining skincare routines.
🔍 Primary Applications 🔍
Prescription Medications: Topical gels/creams for psoriasis and acne.
Anti-Aging Skincare: Serums and creams targeting wrinkles, hyperpigmentation, and sun damage.
Dermatology Research: Study of retinoid pathways and epidermal disorders.
Cosmeceuticals: OTC products for mild acne and skin renewal.
📜 Quality & Compliance 📜
Purity: ≥99% (HPLC)
Standards: USP, EP, and ICH guidelines
Testing: Residual solvents, heavy metals, and stability per ISO 9001
Packaging: Sealed amber vials with nitrogen protection
📈 Market Trends 📈
The global retinoid market is projected to grow at 6.8% CAGR (2023-2030), driven by rising acne prevalence (affecting 9.4% of the global population) and demand for anti-aging solutions. Tazarotene gains traction due to its FDA-approved status for multiple indications and compatibility with combination therapies (e.g., with corticosteroids).
China
